High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,230
+30 (0.25%)
At close: Dec 5, 2025
-11.12%
Market Cap 130.04B
Revenue (ttm) 75.60B
Net Income (ttm) 11.98B
Shares Out 10.63M
EPS (ttm) n/a
PE Ratio 10.85
Forward PE n/a
Dividend 100.00 (0.82%)
Ex-Dividend Date Dec 27, 2024
Volume 13,250
Average Volume 22,789
Open 12,390
Previous Close 12,200
Day's Range 12,030 - 12,390
52-Week Range 11,130 - 16,430
Beta 0.76
RSI 48.34
Earnings Date Nov 12, 2025

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements

News

There is no news available yet.